Healthy Skepticism Library item: 10956
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Henderson JK, Cassady Q.
Drug deals in 2006: cutting edge legal and regulatory issues in the pharmaceutical industry.
Ann Health Law 2006 Win; 15:(1):107-49,
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17552135&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Abstract:
Set amidst the backdrop of rising prescription drug costs and a renewed governmental commitment to combating fraud, this article highlights recent enforcement actions against the pharmaceutical industry. In an effort to clarify today’s turbulent regulatory landscape, the authors also explore the elements of a successful compliance program for pharmaceutical manufacturers and identify the major areas of concern for the future.
Keywords:
MeSH Terms:
Drug Industry/legislation & jurisprudence*
Government Regulation*
United States